Outcome of Board on 25-03-2026
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Kerala Ayurveda Ltd's Board of Directors, at its meeting on March 25, 2026, approved the issuance of 4,000 Series 'A' unlisted, secured, redeemable Non-Convertible Debentures (NCDs) on a private placement basis. Each NCD has a face value of Rs. 1,00,000, taking the total issue size to Rs. 40 Crores at par. The NCDs carry an interest rate of 12% per annum on a reducing balance, payable quarterly, with a tenure of up to 10 years including a 2-year moratorium followed by 32 quarterly instalments for principal repayment. The issue is secured by a first charge on the company's factory land, building, and plant & machinery at Nedumbassery, Ernakulam. The NCDs will not be listed on any stock exchange, and the borrowing is within the limits approved by shareholders on August 22, 2025.
The company is raising Rs. 40 Crores of debt at a relatively high 12% interest rate, which will increase interest expenses and add to its debt burden. While the funds could support business growth, the high cost of borrowing and security on key factory assets signal financial pressure or ambitious expansion plans, which shareholders should monitor closely.